Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 40, 2005 - Issue 8
Submit an article Journal homepage
433
Views
40
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: A randomized, placebo-controlled, double-blind clinical trial

Benno Brinkhaus Institute of Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center, Berlin, Germany; Department of Medicine I, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, GermanyCorrespondence[email protected]
, MD,
Christian Hentschel Department of Medicine I, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany
,
Christoph Von Keudell Department of Medicine I, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany
,
Gernot Schindler Department of Medicine I, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany
,
Martin Lindner Department of Medicine I, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany
,
Hartmut Stützer Institute of Medical Statistics, Informatics and Epidemiology (IMSIE), University of Cologne, Cologne, Germany
,
Ralf Kohnen IMEREM Institute for Medical Research Management and Biometrics, Nuremberg, Germany
,
Stefan N. Willich Institute of Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center, Berlin, Germany
,
Walter Lehmacher Institute of Medical Statistics, Informatics and Epidemiology (IMSIE), University of Cologne, Cologne, Germany
&
Eckhart G. G. Hahn Department of Medicine I, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany
 show all
Pages 936-943 | Received 02 Aug 2004, Published online: 08 Jul 2009

References

  • Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17: 643–50
  • Ehlin AG, Montgomery SM, Ekbom A, Pounder RE, Wakefield AJ. Prevalence of gastrointestinal diseases in two British national birth cohorts. Gut 2003; 52: 1117–21
  • Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119: 654–60
  • Creed F, Ratcliffe J, Fernandez L, Tomenson B, Palmer S, Rigby C, et al. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 2001; 134: 860–8
  • Maxwell PR, Mendall MA, Kumar D. Irritable bowel syndrome. Lancet 1997; 350: 1691–5
  • Fass R, Longstreth GF, Pimentel M, Fullerton S, Russak SM, Chiou CF, et al. Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med 2001; 161: 2081–8
  • Jones J, Boorman J, Cann P, Forbes A, Gomborone J, Heaton K, et al. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000; 47: 1–19
  • Fennerty MB. Traditional therapies for irritable bowel syndrome: an evidence-based appraisal. Rev Gastroenterol Disord 2003; 3: 18–24
  • Mertz HR. Irritable bowel syndrome. N Engl J Med 2003; 349: 2136–46
  • Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000; 133: 136–47
  • Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol 1996; 91: 277–83
  • Langmead L, Chitnis M, Rampton DS. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis 2002; 8: 174–9
  • Spanier JA, Howden CW, Jones MP. A systematic review of alternative therapies in the irritable bowel syndrome. Arch Intern Med 2003; 163: 265–74
  • Ramprasad C, Siri M. Curcuma longa and bile secretion: quantitative changes in the bile constituents induced by sodium curcuminate. J Scientif Industr Res 1957; 16c: 108–10
  • Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973; 25: 447–52
  • Baumann JC, Heintze K, Muth HW. Clinico-experimental studies on the secretion of bile, pancreatic and gastric juice under the influence of phytocholagogous agents of a suspension of Carduus marianus, Chelidonium and Curcuma. Arzneimittelforschung 1971; 21: 98–101
  • Baumann JC. Effect of chelidonium, curcuma, absinthe and Carduus marianus on the bile and pancreatic secretion in liver diseases. Med Monatsschr 1975; 29: 173–80
  • Gruenwald J, Brendler T, Jaenicke C. PDR for herbal medicines. Medical Economics Company, Montvale 2000
  • Cahen R, Sautai M, Taurand S, Luc S. Pharmacological study of fumeterre officinal L. I. Toxicity; cardiovascular, respiratory and hepato-billary actions. Therapie 1964; 19: 357–74
  • Pandey VB, Dasgupta R, Bhattacharyya SK, Lal R, Das PK. Chemistry and pharmacology of the major alkaloids of Fumaria indica (Haussk.). Pugsley Curr Sci 1971; 40: 455–7
  • Giroux J, Boucard M, Beaulaton IS. Modifiers of choleresis: should one speak of amphocholeretics. Therapie 1966; 21: 889–902
  • De Smet PA. Herbal remedies. N Engl J Med 2002; 347: 2046–56
  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–71
  • Hautzinger M, Bailer M, Worall H, Keller F. Beck-Depressions-Inventar (BDI) Testhandbuch. Verlag Hans Huber, Bern 1995
  • Fahrenberg J, Hampel R, Selg H. Freiburger Persönlichkeitsinventar (FPI). Revidierte Fassung FPI-R und teilweise geänderte Fassung FPI-A1. Hogrefe, Göttingen 1994
  • Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE. Rome II: the functional gastrointestinal disorders2nd ed. Degnon, McLean 2000
  • Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988; 95: 232–41
  • Maiwald L. Chronische und akute Obstipation. Z Allgemeinmedizin 1985; 61: 1272–5
  • Roux M. Le nébulisat de fumeterre dans la régulation des troubles intestinaux chroniques d'origine biliare. Gaz Méd de France 1978; 84: 3794–808
  • Sood GK, Baijal SS, Lahoti D, Broor SL. Abnormal gallbladder function in patients with irritable bowel syndrome. Am J Gastroenterol 1993; 88: 1387–90
  • Zacharewicz M, Chorazy W, Mossor S, Zacharewicz M, Jr. Treatment of cholecystopathies by Fumaria nebulisate. Wien Med Wochenschr 1979; 129: 221–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.